Situation update worldwide Data presented on this page are collected between Monday and Wednesday for the preceding week and published on Thursdays Disclaimer: National updates are published at different times and in different time zones. This, and the time ECDC needs to process these data, may lead to discrepancies between the national numbers and the numbers published by ECDC. Users are advised to use all data with caution and awareness of their limitations. Data are subject to retrospective corrections; corrected datasets are released as soon as processing of updated national data has been completed. Download latest data How are the data collected? Since 31 December 2019 and as of week 2022-06, 411 553 140 cases of COVID-19 (in accordance with the applied case definitions and testing strategies in the affected countries) have been reported, including 5 829 356 deaths. Cases have been reported from: Other: 705 cases have been reported from an international conveyance in Japan. Deaths have been reported from:
World Economic Forum: The Institution Behind ‘The Great Reset’ – Steven Guinness In a recent article I briefly examined a number of advances that global planners made prior to the World Economic Forum’s announcement in June of a new initiative dubbed ‘The Great Reset‘. Taken together, the United Nation’s Agenda 2030, the Paris Climate Agreement, the Fourth Industrial Revolution and the Bank for International Settlement’s ‘Innovation BIS 2025‘ offer an insight into how elites want to turn the lives of every man, woman and child inside out over the course of the next decade. Details of ‘The Great Reset‘ came as nations began to reopen their economies following a global lockdown. The extent to which Covid-19 has dominated every facet of existence – largely because of unrepentant media coverage – has encouraged people to focus exclusively on what life will be like after the virus. For many, what came before now seems inconsequential. It is anything but. That pandemic arrived in the shape of Covid-19, just weeks after the conclusion of Event 201. Who are the co-curators?
Info Coronavirus COVID-19 Dans son avis du 30 mars 2023, la Haute Autorité de Santé préconise de lever l’obligation vaccinale contre le Covid-19 pour les professionnels de santé. L’obligation vaccinale est levée par décret à compter du 15 mai 2023. Les modalités de réintégration sont précisées dans l’instruction interministérielle n° DGOS/RH3/RH4/RH5/DGCS/2023/63 du 2 mai 2023 relative aux modalités de réaffectation des agents à la suite de la levée de l’obligation vaccinale contre le Covid-19. La vaccination des professionnels de santé reste toutefois fortement recommandée. Depuis le 1er mars 2023, l’Assurance maladie prend en charge une partie des frais liés aux tests de dépistage (antigénique et RT-PCR) du Covid-19 de tous ses assurés sans prescription. Plusieurs changements ont aussi pris effet en février 2023 : Je suis positif au Covid-19, que dois-je faire ? Je prends rendez-vous pour me faire vacciner Port du masque Le port du masque demeure recommandé: Maintenons les gestes barrières Isolement Tests Vaccination
Seeing Coronavirus Replicate in Kidney Cells Posted on July 7th, 2020 by Dr. Francis Collins You’ve probably seen pictures of SARS-CoV-2—the novel coronavirus that causes COVID-19—that look alarming. But the high-resolution micrograph above paints a rather different picture, using rich pseudo-colors to show how newly assembled viral particles cause infected cells to bulge, or bleb, and then self-destruct. This image depicts a common primate kidney cell line (green) infected with SARS-CoV-2. This stunning picture was taken by John Bernbaum, an electron microscopist with NIH’s National Institute of Allergy and Infectious Diseases (NIAID). To get this shot of SARS-CoV-2, Bernbaum relied on a conventional scanning electron microscope (SEM). Originally, this image was in gray scale. Interestingly, what Bernbaum finds most striking about SARS-CoV-2 is what you don’t see in his images. Bernbaum has been producing amazing images like this one for 32 years—the last 11 of them at the IRF. Links: Coronavirus (NIH)
Coronavirus : suivez la propagation de la pandémie en France et dans le monde Cette page est obsolète Une nouvelle page de suivi est désormais disponible pour suivre l'état de la pandémie de Covid-19. Cette page, bien qu'automatisée, ne sera plus maintenue. Vous serez redirigé vers la nouvelle page de suivi dans 18 secondes. La pandémie de Covid-19 qui sévit dans le monde a désormais touché plus de 170 pays à travers la planète, et progresse de plus en plus rapidement dans le monde, et notamment dans les pays européens, devenus le principal foyer mondial, après que le virus a durement frappé la Chine, d’où il est parti. Etat de la pandémie dans le monde Malades : ( %) Morts : ( %) Guéris : ( %) Au #REF! Le graphique ci-dessous représente l'évolution de la pandémie dans le temps. La situation de l’épidémie en France En France, les cas détectés sur le territoire métropolitain n’étaient que, jusqu’à fin février, des cas importés d’autres pays (typiquement des touristes français de retour d’une zone infectée ou des touristes étrangers en visite). Mis à jour le #REF! en 24 h
Enlisting Monoclonal Antibodies in the Fight Against COVID-19 Posted on May 21st, 2020 by Dr. Francis Collins We now know that the immune system of nearly everyone who recovers from COVID-19 produces antibodies against SARS-CoV-2, the novel coronavirus that causes this easily transmitted respiratory disease [1]. The presence of such antibodies has spurred hope that people exposed to SARS-CoV-2 may be protected, at least for a time, from getting COVID-19 again. In a recent paper in the journal Science, researchers used blood drawn from a COVID-19 survivor to identify a pair of previously unknown antibodies that specifically block SARS-CoV-2 from attaching to human cells [2]. The research team, led by Yan Wu, Capital Medical University, Beijing, first isolated the pair of antibodies in the laboratory, starting with white blood cells from the patient. Monoclonal antibodies are currently used to treat a variety of conditions, including asthma, cancer, Crohn’s disease, and rheumatoid arthritis. References: Links: Coronavirus (COVID-19) (NIH)
esri As hundreds of millions of eyes stay glued to the rising toll and reach of the novel coronavirus disease 2019 (COVID-19), map-based dashboards have become a compelling, near real-time way to monitor the outbreak. They’ve also substantiated the message that everyone must take precautions and alter daily interactions. When the World Health Organization (WHO) declared COVID-19 a pandemic, director-general Tedros Adhanom Ghebreyesus warned that the situation would worsen. Yet, he noted, this is the first world pandemic that can be controlled, in part due to global connectivity and awareness. The controllability of COVID-19 can also be attributed to tools that quantify data inputs—and aggregate information about who and when in the context of where. See the COVID-19 GIS Hub for location intelligence resources. Analyzing and Containing Outbreaks Health analysts are using GIS to track the situation across space and time. Anticipating Vulnerabilities and Ramping Up Care Capacity About the authors
Capturing Viral Shedding in Action Posted on April 28th, 2020 by Dr. Francis Collins You’ve probably seen some amazing high-resolution images of SARS-CoV-2, the novel coronavirus that causes COVID-19, on television and the web. The head of RML’s Electron Microscopy Unit, Elizabeth Fischer, was the researcher who took this portrait of SARS-CoV-2. The NIAID facility uses a variety of microscopy techniques, including state-of-the-art cryo-electron microscopy (cryo-EM). SEM enables visualization of particles, including viruses, that are too small to be seen with traditional light microscopy. So, what exactly are you seeing in this image? This picture is quite literally a snapshot of viral shedding, a process in which viral particles are released from a dying cell. While capturing a fixed sample on the microscope is fairly straightforward for a pro like Fischer, developing a sample like this one involves plenty of behind-the-scenes trial and error by NIAID investigators. Links: Coronavirus (COVID-19) (NIH)